234 related articles for article (PubMed ID: 26097734)
1. Recent treatment advances and novel therapeutic approaches in epilepsy.
Serrano E; Kanner AM
F1000Prime Rep; 2015; 7():61. PubMed ID: 26097734
[TBL] [Abstract][Full Text] [Related]
2. Antiepileptic drugs: evolution of our knowledge and changes in drug trials.
Perucca E
Epileptic Disord; 2019 Aug; 21(4):319-329. PubMed ID: 31403463
[TBL] [Abstract][Full Text] [Related]
3. Transcranial magnetic stimulation for the diagnosis and treatment of epilepsy.
Kimiskidis VK; Valentin A; Kälviäinen R
Curr Opin Neurol; 2014 Apr; 27(2):236-41. PubMed ID: 24553462
[TBL] [Abstract][Full Text] [Related]
4. [Therapeutic advances in refractory epilepsies in children].
Korff CM; Lebon S; Roulet-Perez E
Rev Med Suisse; 2012 Feb; 8(329):413-4, 416-7. PubMed ID: 22432242
[TBL] [Abstract][Full Text] [Related]
5. Newer antiepileptic drugs. Towards an improved risk-benefit ratio.
Patsalos PN; Sander JW
Drug Saf; 1994 Jul; 11(1):37-67. PubMed ID: 7917080
[TBL] [Abstract][Full Text] [Related]
6. Decision Models for Assessing the Cost Effectiveness of Treatments for Pediatric Drug-Resistant Epilepsy: A Systematic Review of Economic Evaluations.
Elliott J; van Katwyk S; McCoy B; Clifford T; Potter BK; Skidmore B; Wells GA; Coyle D
Pharmacoeconomics; 2019 Oct; 37(10):1261-1276. PubMed ID: 31201643
[TBL] [Abstract][Full Text] [Related]
7. New antiepileptic drugs in children: present and future.
Pellock JM; Watemberg N
Semin Pediatr Neurol; 1997 Mar; 4(1):9-18. PubMed ID: 9097362
[TBL] [Abstract][Full Text] [Related]
8. Current challenges in the treatment of epilepsy.
Mattson RH
Neurology; 1994 Jun; 44(6 Suppl 5):S4-9; discussion S31-2. PubMed ID: 8022538
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo experimental models employed in the discovery and development of antiepileptic drugs for pharmacoresistant epilepsy.
Campos G; Fortuna A; Falcão A; Alves G
Epilepsy Res; 2018 Oct; 146():63-86. PubMed ID: 30086482
[TBL] [Abstract][Full Text] [Related]
10. [New antiepileptic drugs, and therapeutic considerations].
Szupera Z
Ideggyogy Sz; 2011 Sep; 64(9-10):329-32. PubMed ID: 22059370
[TBL] [Abstract][Full Text] [Related]
11. Genetic basis for idiosyncratic reactions to antiepileptic drugs.
Franciotta D; Kwan P; Perucca E
Curr Opin Neurol; 2009 Apr; 22(2):144-9. PubMed ID: 19262378
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in the diagnosis and management of epilepsy.
Fong GC; Fong JK
Hong Kong Med J; 2001 Mar; 7(1):73-84. PubMed ID: 11406679
[TBL] [Abstract][Full Text] [Related]
13. New horizons in the development of antiepileptic drugs.
Löscher W; Schmidt D
Epilepsy Res; 2002 Jun; 50(1-2):3-16. PubMed ID: 12151112
[TBL] [Abstract][Full Text] [Related]
14. Future antiepileptic drug development.
Bergey GK
Neurology; 2000; 55(5 Suppl 1):S47-53; discussion S54-8. PubMed ID: 11001362
[TBL] [Abstract][Full Text] [Related]
15. Critical re-evaluation of previous preclinical strategies for the discovery and the development of new antiepileptic drugs.
Löscher W; Leppik IE
Epilepsy Res; 2002 Jun; 50(1-2):17-20. PubMed ID: 12151113
[TBL] [Abstract][Full Text] [Related]
16. Development of new antiepileptic drugs: challenges, incentives, and recent advances.
Perucca E; French J; Bialer M
Lancet Neurol; 2007 Sep; 6(9):793-804. PubMed ID: 17706563
[TBL] [Abstract][Full Text] [Related]
17. Novel approaches to anticonvulsant drug discovery.
Miziak B; Chrościńska-Krawczyk M; Błaszczyk B; Radzik I; Czuczwar SJ
Expert Opin Drug Discov; 2013 Nov; 8(11):1415-27. PubMed ID: 24050182
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in epilepsy.
Manford M
J Neurol; 2017 Aug; 264(8):1811-1824. PubMed ID: 28120042
[TBL] [Abstract][Full Text] [Related]
19. [New treatments in epilepsy].
Arroyo S
Neurologia; 1999 Dec; 14 Suppl 6():13-20. PubMed ID: 10659601
[TBL] [Abstract][Full Text] [Related]
20. Novel approaches to epilepsy treatment.
Sørensen AT; Kokaia M
Epilepsia; 2013 Jan; 54(1):1-10. PubMed ID: 23106744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
